To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Multiple myeloma (MM)
In vitro and mouse studies identified a quinazolinone-based inhibitor of PIM1 and PIM2
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury